NeuPath Health Inc.
NPTH.V
TSX
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 186.50K | -287.80K | -175.00K | -294.00K | 216.30K |
Total Depreciation and Amortization | 414.90K | 416.00K | 420.10K | 421.60K | 404.10K |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 168.40K | 253.60K | 173.60K | 212.60K | 209.70K |
Change in Net Operating Assets | -829.00K | 581.10K | -121.40K | 310.90K | 57.70K |
Cash from Operations | -59.30K | 963.00K | 297.20K | 651.10K | 887.90K |
Capital Expenditure | -106.20K | -21.60K | -192.20K | -148.10K | -314.20K |
Sale of Property, Plant, and Equipment | -- | -- | 11.40K | -- | -- |
Cash Acquisitions | -- | -- | 0.00 | 0.00 | 0.00 |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -106.20K | -21.60K | -180.70K | -148.10K | -314.20K |
Total Debt Issued | 0.00 | 6.50M | -25.00K | 25.00K | -- |
Total Debt Repaid | -439.00K | -6.32M | -356.00K | -478.00K | -475.00K |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -50.00K | -57.00K | -24.00K | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 134.00K | 31.00K | 24.00K | 24.00K | 24.00K |
Cash from Financing | -256.60K | 108.00K | -272.20K | -314.50K | -329.60K |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -422.10K | 1.05M | -155.70K | 188.40K | 244.10K |